It has been shown that alternate-day fasting alleviates high-fat diet-induced NAFLD in a mouse model through the activation of peroxisome proliferator-activated receptor alpha (PPARα), which, in turn, regulates fibroblast growth factor 21 (FGF21) expression [126]. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.